| Denumire comercială | DCI | Forma farmaceutică | Cod ATC | Cod CIM | Firma / țara deținătoare APP |  |
 |
 |
 |
 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| FENOFIBRAT TERAPIA 160 mg | FENOFIBRATUM | COMPR. FILM. | C10AB05 | W53437001 | TERAPIA SA - ROMANIA | ||||||
| FENOFIBRAT TERAPIA 160 mg | FENOFIBRATUM | COMPR. FILM. | C10AB05 | W53437002 | TERAPIA SA - ROMANIA | ||||||
| FENTANIL KALCEKS 50 micrograme/ml | FENTANYLUM | SOL. INJ. | N01AH01 | W67084001 | AKCIJU SABIEDRIBA KALCEKS - LETONIA | ||||||
| FENTANIL KALCEKS 50 micrograme/ml | FENTANYLUM | SOL. INJ. | N01AH01 | W67084002 | AKCIJU SABIEDRIBA KALCEKS - LETONIA | ||||||
| FENTANYL LAVIPHARM 100 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63129001 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 100 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63129002 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 100 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63129003 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 100 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63129004 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 100 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63129005 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 100 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63129006 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 100 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63129007 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 100 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63129008 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 100 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63129009 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 12 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63125001 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 12 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63125002 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 12 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63125003 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 12 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63125004 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 12 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63125005 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 12 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63125006 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 12 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63125007 | LAVIPHARM S.A. - GRECIA |
ANMDMR - Nomenclatorul medicamentelor pentru uz uman